Abstract
Seltorexant is a potent and selective antagonist of the orexin-2 receptor that is being developed for the treatment of insomnia and major depressive disorder. The primary objective was to investigate the effect of seltorexant on sleep efficiency after single and multiple dose administration in subjects with insomnia disorder without psychiatric comorbidity. Secondary objectives included evaluation of total sleep time, latency to persistent sleep, and wake after sleep onset. Subjects received 40 mg of seltorexant for five days during Period 1 and placebo during Period 2 or vice versa in this randomized, two-way crossover study. Objective sleep parameters were evaluated by polysomnography over 8 h on Day 1/2 (single dose) and on Day 5/6 (multiple doses). Subjective sleep parameters were assessed by questionnaires. Twenty-seven subjects completed the study. The mean changes in sleep efficiency (% (SD)) of seltorexant from placebo at Day 1/2 were 5.8 (9.2), and 7.9 (9.8) at Day 5/6 ( p < 0.001 at both time points); in total sleep time (min (SD)) 27.7 (44.3) and 37.9 (47.1), respectively; in latency to persistent sleep (min (SD)) -18.8 (21.3) and -29.9 (27.7), respectively; and in wake after sleep onset (min (SD)) -11.1 (36.4) and -...Continue Reading
References
May 1, 1990·The International Journal of Neuroscience·T Akerstedt, M Gillberg
Jan 1, 1980·Psychopharmacology·A C Parrott, I Hindmarch
May 23, 2001·The Journal of Comparative Neurology·J N MarcusJ K Elmquist
Jan 18, 2003·Sleep Medicine Reviews·Maurice M Ohayon
Jun 29, 2005·Journal of the American Geriatrics Society·Andrew D Krystal
Oct 17, 2006·Sleep·Daniel J BuysseCharles M Morin
Oct 4, 2007·Frontiers in Neuroendocrinology·Kousaku Ohno, Takeshi Sakurai
Apr 14, 2009·The Journal of Pharmacology and Experimental Therapeutics·Christine DugovicTimothy W Lovenberg
Sep 11, 2010·Neuropsychobiology·Peter AndererGeorg Dorffner
Nov 3, 2010·Annual Review of Pharmacology and Toxicology·Thomas E Scammell, Christopher J Winrow
Dec 1, 2012·Neurology·W Joseph HerringDavid Michelson
Jan 30, 2013·CNS Drugs·Michihiro Mieda, Takeshi Sakurai
Apr 5, 2013·Science Translational Medicine·Jason M UslanerJohn J Renger
Mar 5, 2014·Frontiers in Neuroscience·Christine DugovicTimothy W Lovenberg
Aug 2, 2014·Nature Reviews. Drug Discovery·Stacy R LindborgStephen J Ruberg
Dec 21, 2014·Biological Psychiatry·W Joseph HerringDavid Michelson
Jan 24, 2015·Bioorganic & Medicinal Chemistry Letters·Anthony J RoeckerPaul J Coleman
Jul 17, 2015·The Journal of Pharmacology and Experimental Therapeutics·Pascal BonaventureChristine Dugovic
Jun 3, 2016·Journal of Clinical Psychopharmacology·Kerri A SchoedelJohn A Wagner
Dec 25, 2016·Current Topics in Behavioral Neurosciences·Shi-Bin LiLuis de Lecea
Nov 22, 2017·Current Biology : CB·John Peever, Patrick M Fuller
Citations
Jan 16, 2019·Journal of Psychopharmacology·Sander BrooksWayne Drevets
Mar 30, 2019·Sleep·Carsten Theodor BeuckmannShigeru Akasofu
Apr 28, 2020·Neuropsychopharmacology Reports·Shunsuke MaeharaTakashi Takeuchi
Jun 17, 2020·Neuropsychopharmacology Reports·Timothy A RoehrsGarth Whiteside
Sep 5, 2019·Translational Psychiatry·Kasper RecourtWayne Drevets
Sep 10, 2020·Expert Opinion on Drug Metabolism & Toxicology·Clemens MuehlanJasper Dingemanse
Nov 30, 2019·Neuroscience Bulletin·Ying HanLin Lu
Jul 17, 2019·Bioorganic & Medicinal Chemistry Letters·Younggi Choi, Brian K Raymer
Apr 19, 2020·Sleep·Thomas C NeylanThomas S Kilduff
Feb 12, 2021·Neurobiology of Stress·Dan WangQianzi Yang
Mar 13, 2021·Expert Opinion on Pharmacotherapy·Gary Zammit, Andrew Krystal
Mar 13, 2021·Translational Research : the Journal of Laboratory and Clinical Medicine·Mark K GreenwaldTimothy A Roehrs
Jul 30, 2021·The International Journal of Neuropsychopharmacology·Adam SavitzWayne C Drevets
Jul 22, 2020·The Journal of Organic Chemistry·Fang-Fang FengJun-An Ma
Aug 21, 2021·Psychopharmacology·Catherine RochMartine Clozel
Aug 31, 2021·Organic Letters·Jingwen LiangZhongzhi Zhu
Oct 11, 2021·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Victoria L RevellDerk-Jan Dijk
Nov 19, 2021·The International Journal of Neuropsychopharmacology·Manish Kumar Jha
Jan 20, 2022·Journal of Internal Medicine·Laura H JacobsonLuis de Lecea